Protalix BioTherapeutics, Inc.
PLX
|
$1.13
310K
|
Health Services
(0.0% 1d) (-15.7% 1m) (-51.5% 1y) (0.0% 2d) (-1.7% 3d) (-0.9% 7d) (16.61% volume)
Earnings Calendar:
Market Cap: $ 82,548,900
http://www.protalix.com
Sec Filling | Patents | 196 employees
(IL) Protalix Biotherapeutics, Inc. engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa and OPRX-106. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Karmiel, Israel.
israel t-cell ceiling
add to watch list Paper trade email alert is off
Press-releases
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results
Published: 2024-03-14 (Crawled : 11:00) - biospace.com/
PLX | $1.13 310K
|
Health Services
|
| O: 1.32%
H: 0.0%
C: -11.04%
business year financial results
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024
Published: 2024-03-07 (Crawled : 16:00) - biospace.com/
PLX | $1.13 310K
|
Health Services
|
| O: 1.35%
H: 0.0%
C: -2.67%
business year financial results
Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference
Published: 2024-02-23 (Crawled : 12:00) - prnewswire.com
PLX | $1.13 310K
|
Health Services
|
| O: 0.7%
H: 4.17%
C: 0.69%
ceo conference
Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference
Published: 2024-02-23 (Crawled : 22:00) - biospace.com/
PLX | $1.13 310K
|
Health Services
|
| O: 0.7%
H: 4.17%
C: 0.69%
ceo conference
Protalix BioTherapeutics Issues 2024 Letter to Stockholders
Published: 2023-12-26 (Crawled : 12:00) - prnewswire.com
PLX | $1.13 310K
|
Health Services
|
| O: 0.56%
H: 4.97%
C: 1.66%
Levicept Appoints Eliot Forster as CEO
Published: 2023-11-30 (Crawled : 11:00) - biospace.com/
IMCR | $55.83 1.99% 89K
|
Manufacturing
|
| O: 0.14%
H: 7.22%
C: 6.68%
IMTX | $10.205 -0.54% 34K
|
Health Technology
|
| O: 1.63%
H: 1.83%
C: 1.14%
PLX | $1.13 310K
|
Health Services
|
| O: 0.0%
H: 6.29%
C: 5.59%
ceo
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023
Published: 2023-10-30 (Crawled : 23:00) - biospace.com/
PLX | $1.13 310K
|
Health Services
|
| O: 0.0%
H: 4.2%
C: 4.2%
business financial results
Protalix BioTherapeutics Reports Second Quarter 2023 Financial and Business Results
Published: 2023-08-07 (Crawled : 12:00) - biospace.com/
PLX | $1.13 310K
|
Health Services
|
| O: 12.43%
H: 1.58%
C: 0.0%
business financial results
Protalix BioTherapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
Published: 2023-08-01 (Crawled : 12:00) - biospace.com/
PLX | $1.13 310K
|
Health Services
|
| O: -2.15%
H: 2.52%
C: 2.52%
conference growth
Protalix BioTherapeutics to Host In-Person KOL Breakfast following the Approval of Elfabrio® in both the United States and the European Union for Adults with Fabry Disease
Published: 2023-06-08 (Crawled : 13:00) - biospace.com/
PLX | $1.13 310K
|
Health Services
|
| O: 0.41%
H: 1.02%
C: -4.51%
elfabrio disease approval
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 78% | 22% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
NVFY | $3.45 63.51% 20M
|
Consumer Durables
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
ZCMD | $1.86 28.28% 29M
|
Commercial Services
PAPL | $2.07 26.22% 550K
|
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
Last 48 Hours Insiders Buying
CLSD | $1.42 7.58% 130K
|
Health Technology
|
14:00
CDZI P 25000 | $2.275 1.11% 74K
|
Utilities
|
14:00
ETST P 39000 | $0.068 43K
|
Manufacturing
|
13:30
FNLC P 1275 | $22.62 2.08% 8K
|
Finance
|
12:30
ADMQ | $0.0532 480K
|
|
10:30
AXR P 2400 | $22.26 0.41% 180
|
Finance
|
21:00
QCRH P 118 | $56.105 1.25% 11K
|
Finance
|
18:01
VUZI P 7500 | $1.245 -1.19% 140K
|
Electronic Technology
|
18:00
RMCF | $3.5501 390
|
Consumer Non-Durables
|
20:10